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Lif1p targets the DNA ligase Lig4p to sites of DNA
double-strand breaks
Soo-Hwang Teo and Stephen P. Jackson
DNA ligases catalyse the joining of DNA single- and
double-strand breaks. Saccharomyces cerevisiae
Cdc9p is a homologue of mammalian DNA ligase I and is
required for DNA replication, recombination and
single-strand break repair. The other yeast ligase,
Lig4p/Dnl4p, is a homologue of mammalian DNA ligase IV,
and functions in the non-homologous end-joining (NHEJ)
pathway of DNA double-strand break repair [1–4]. Lig4p
interacts with Lif1p, the yeast homologue of the human
ligase IV-associated protein, XRCC4 [5]. This interaction
takes place through the carboxy-terminal domain of
Lig4p and is required for Lig4p stability. We show that the
carboxy-terminal interaction region of Lig4p is necessary
for NHEJ but, when fused to Cdc9p, is insufficient to confer
NHEJ function to Cdc9p. Also, Lif1p stimulates the in vitro
catalytic activity of Lig4p in adenylation and DNA ligation.
Nevertheless, Lig4p is inactive in NHEJ in the absence of
Lif1p in vivo, even when Lig4p is stably expressed. We
show that Lif1p binds DNA in vitro and, through in vivo
cross-linking and chromatin immuno precipitation
assays, demonstrate that it targets Lig4p to chromosomal
DNA double-strand breaks. Furthermore, this targeting
requires another key NHEJ protein, Ku.
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Results and discussion
The carboxy-terminal region of Lig4p/Dnl4p that binds
Lif1p contains two motifs that are homologous to the
BRCA1 carboxyl terminus [6]. These ‘BRCT domains’
occur in several DNA repair and DNA damage signalling
components, and the BRCT domain of XRCC1 was shown
recently to have a compact globular structure [7]. In human
DNA ligase IV, the two BRCT domains are separated by a
linker region that is necessary and sufficient for interaction
with human XRCC4 [8]. To investigate which region(s) of
Lig4p interact with Lif1p and are required for NHEJ
in vivo, we generated a series of epitope-tagged Lig4p
derivatives. Immunoprecipitations were performed with
anti-FLAG or control antibodies from whole-cell extracts
of lig4 mutant yeast expressing FLAG-epitope-tagged
Lif1p and epitope-tagged Lig4p derivatives. The pres-
ence of the Lig4p derivative in the immunoprecipitated
material was then assessed by Western blotting. Concomi-
tantly, lig4 mutant yeast expressing the Lig4p derivatives
were transformed with linear or supercoiled forms of a
yeast–Escherichia coli shuttle plasmid, and the number of
transformants obtained with linear DNA compared to the
number with supercoiled DNA was scored as a measure of
in vivo NHEJ activity. Figure 1a shows that an epitope-
tagged derivative of Lig4p was able to interact with Lif1p
(lane 3) and to perform NHEJ efficiently (right panel).
Truncation of the entire Lig4p carboxy-terminal region
abolished interaction with Lif1p and resulted in a concomi-
tant abrogation of NHEJ activity (Figure 1b). This carboxy-
terminal region was sufficient for interaction with Lif1p
(Figure 1c). Moreover, a Lig4p fusion protein lacking both
BRCT domains, but retaining the inter-BRCT linker
region, still interacted with Lif1p (Figure 1d), indicating
that, as for human ligase IV [8], the linker region of Lig4p is
sufficient for interaction with Lif1p. Strikingly, although the
BRCT-deleted form of Lig4p still interacted with Lif1p, its
NHEJ activity was abrogated (Figure 1d). 
The only other S. cerevisiae DNA ligase, Cdc9p, does not
have a carboxy-terminal extension like Lig4p, but has an
amino-terminal extension that interacts with proliferating
cell nuclear antigen (PCNA) [9,10]. Overexpression of
Cdc9p does not rescue the NHEJ defect of a lig4 mutant
(Figure 1e). Because the carboxy-terminal region of Lig4p
was sufficient for interaction with Lif1p (Figure 1c, lane 3)
and contained the BRCT domains necessary for NHEJ, we
reasoned that fusion of this region to Cdc9p might confer
NHEJ activity on this ligase. Notably, although the result-
ing fusion protein interacted with Lif1p, it was totally inac-
tive for NHEJ (Figure 1f). To address the possibility that
this might be due to a simultaneous interaction with PCNA
at replication foci, we constructed a fusion protein lacking
the amino-terminal PCNA-interacting region of Cdc9p.
This fusion protein interacted with Lif1p but still had no
detectable NHEJ activity (Figure 1g). This suggests that,
although the carboxy-terminal extension of Lig4p which
interacts with Lif1p is necessary for its activity in vivo, other
differences between Cdc9p and Lig4p also delineate the
separate functions of these two DNA ligases in vivo.
Yeast and human lif1 mutant cells have no detectable
Lig4p, indicating that Lif1p stabilises Lig4p [5,11]. The
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converse appears not to be true, however — western blot
analysis using antibodies raised against two different epi-
topes of Lif1p showed that Lif1p was stably expressed in
lig4 mutant cells (Figure 2a, top panel and data not shown).
Neither lig4 nor lif1 mutants could perform NHEJ plasmid
repair (Figure 2b). The instability of Lig4p in the lif1
mutant background suggested that the role of Lif1p in
NHEJ might simply be to stabilise Lig4p. We therefore
reasoned that stable overexpression of Lig4p might rescue
the lif1 mutant phenotype. To test this idea, we constructed
a haemagglutinin (HA)-epitope-tagged derivative of Lig4p
expressed under the control of the GAL1–10 promoter. The
tagged derivative of Lig4p was expressed at similar levels in
the presence or absence of Lif1p (Figure 2a, middle panel,
compare lane 6 with lane 8) and was nuclear (data not
shown). Notably, whereas overexpression of tagged Lig4p
complemented the lig4 mutant phenotype, its overexpres-
sion did not lead to any recovery of in vivo plasmid end-
joining activity in the lif1 mutant background (Figure 2b,
columns 6,8). These data reveal that, in addition to stabilis-
ing Lig4p, Lif1p performs other essential roles in NHEJ. 
One other way in which Lif1p might function is by poten-
tiating Lig4p catalytic activity. Indeed, the human Lif1p
homologue, XRCC4, stimulates DNA ligase IV activity
in vitro [12,13]. We therefore expressed and purified from
yeast cells HA-tagged Lig4p, either without Lif1p or in a
complex with FLAG-epitope-tagged Lif1p, then tested
the activity of these proteins in vitro in adenylation and
DNA ligation assays. DNA ligases form a covalent interme-
diate with ATP in the absence of DNA that can be readily
detected by incubating the protein with [α-32P]ATP.
Figure 3a (bottom panel) shows that, in this assay, purified
Lig4p formed a stable adenylated protein (lanes 1–3). This
adenylation activity was stimulated 2–4-fold by purified
recombinant Lif1p (lanes 4–6), to a level similar to that of
the purified Lig4p/Lif1p complex (lanes 7–9). To test the
activity of purified Lig4p in the ligation of double-stranded
DNA, increasing amounts of purified Lig4p, Lig4p with
recombinant Lif1p (rLif1p), or the Lig4p/Lif1p complex
purified from yeast, were incubated with linearised pBlue-
script plasmid and the products were analysed on an
agarose gel. Lig4p weakly catalysed plasmid DNA multi-
merisation (Figure 3b, lanes 2–4), regardless of whether the
plasmid had 5′ overhangs, 3′ overhangs or blunt ends. The
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Figure 2
Lif1p is stable in the absence of Lig4p and is
essential for NHEJ. (a) Approximately 100 µg
of whole-cell extracts of the indicated yeast
strains were analysed by western blotting
using rabbit anti-Lif1p (top), mouse anti-HA
(middle; to detect Lig4p) or rat anti-β-tubulin
(bottom) antibodies. (b) Yeast strains were
grown in medium containing glucose
(glu; lanes 1–5,7) or galactose (gal; lanes
6,8) and transformed with either supercoiled
or XbaI-linearised pRS415. Repair efficiency
was scored as the number of Leu+ colonies
obtained using linear DNA as a percentage
of the number obtained using supercoiled
DNA, and were an average of three
independent experiments.
Figure 1
(a–g) Left: Schematic representation of the various galactose-inducible
epitope-tagged derivatives of Lig4p or Cdc9p or fusion proteins; plus
sign, two copies of the haemagglutinin tag; asterisk, V5 epitope tag;
black, Lig4p ligase domain; dark grey, Lig4p BRCT domains; white,
Cdc9p ligase domain; light grey, Cdc9p amino-terminal domain.
Middle: Proteins were expressed in a lig4 mutant strain expressing
FLAG-epitope-tagged Lif1p. As controls, V5- or HA-tagged Lig4p or
Cdc9p fusion proteins were immunoprecipitated with antibodies specific
to their epitope tags (lane 1) or an irrelevant monoclonal antibody
(lane 2). Interaction with FLAG-tagged Lif1p was assessed by
immunoprecipitation using mouse anti-FLAG antibodies (lane 3) followed
by western blotting to detect epitope-tagged Lig4p or Cdc9p derivatives.
Right: Plasmid repair assays were performed using a lig4 mutant strain
expressing the various fusion proteins. Repair efficiency (expressed as a
percentage of that obtained with a wild-type strain) was scored by
measuring the number of Leu+ colonies arising following transformation
with XbaI-linearised pRS415 versus supercoiled pRS415, and were an
average of three independent experiments. Similar results were obtained
using EcoRI-linearised plasmid pBTM116 (data not shown).
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activity was greater with 5′ or 3′ overhangs than with blunt
ends (data not shown). Addition of Lif1p stimulated this
activity 2–4-fold (Figure 3b, lanes 5–7) to a level of activity
similar to that of the purified Lig4p/Lif1p complex
(lanes 11–13). Lif1p protein itself had no ligase activity
(Figure 3b, lanes 8–10) and a non-specific protein (acety-
lated bovine serum albumin) had no effect on Lig4p activ-
ity (data not shown). The fact that the stimulation of DNA
ligation is comparable with the stimulation of adenylation
activity suggests that Lif1p stimulates Lig4p catalytic
activity by increasing the ability of Lig4p to form a pre-
adenylated activated complex.
Because Lig4p was significantly active in the absence of
Lif1p in vitro but did not appear to have any detectable
end-joining activity in vivo, we reasoned that Lif1p might
be necessary for targeting of Lig4p to double-strand breaks
within the cell. We therefore tested the ability of Lif1p to
bind DNA in vitro using the gel retardation assay. Recombi-
nant Lif1p bound co-operatively to a double-stranded DNA
molecule of 335 bp in a manner similar to that shown previ-
ously for its human homologue XRCC4 (Figure 4a) [13].
However, the apparent selectivity of Lif1p for linear over
supercoiled DNA in competition assays was found to be
less than that observed with XRCC4 (data not shown) [13].
Moreover, we tested the binding of Lif1p and Lig4p to
double-strand breaks in vivo. To do this, we induced a
single double-strand break in the MAT locus in the yeast
genome by expressing the HO endonuclease in cells that
were mutated for rad52. In these cells, homologous recom-
bination is abrogated and cells can repair the double-strand
break only via the LIG4-dependent NHEJ pathway. 
We then performed in vivo cross-linking experiments fol-
lowed by chromatin immunoprecipitations using antibod-
ies against FLAG-tagged Lif1p, HA-tagged Lig4p or
endogenous Lif1p (Figure 4b, top, middle and bottom
panels, respectively). The in vivo localisation of Lif1p or
Lig4p to the MAT locus was then assessed by subjecting
the immunoprecipitates to PCR with MAT locus-specific or
control primers (see the Supplementary material).
Figure 4b (top panel) shows that a PCR product derived
from the MAT locus was generated from Lif1p immunopre-
cipitates regardless of whether or not they contained
Lig4p. Consistent with this localisation of Lif1p being trig-
gered by the induction of a DNA double-strand break, the
PCR product was detected in immunoprecipitates derived
from cells that had been grown in the presence of galac-
tose, which leads to HO expression, but not from those of
cells grown under HO-repressing conditions (compare
lanes 4–6 with lanes 1–3). Immunoprecipitation of Lig4p
also retrieved MAT locus DNA (Figure 4b, middle panel).
Notably, however, this occurred only in the presence but
not in the absence of Lif1p (compare lanes 5 and 6, respec-
tively). We also performed experiments with antibodies
raised against endogenous Lif1p, with similar results to
those obtained with epitope-tagged Lif1p (Figure 4c,
bottom panel, lanes 4 and 6). Thus, Lif1p is detected near
the DNA double-strand break in the presence or absence
of Lig4p, whereas it appears that Lig4p is targeted to such
sites only when it is complexed with Lif1p.
Another protein involved in NHEJ is the DNA end-binding
protein Ku, and recent work has shown that Ku rapidly asso-
ciates with DNA double-strand breaks in vivo [14,15]. We
therefore tested whether the targeting of Lif1p and/or
Lig4p to sites of DNA damage in vivo might be depen-
dent on Ku. Strikingly, in contrast to the situation in the
presence of Ku, where Lif1p is targeted to the MAT locus
upon HO cleavage (Figure 4c, bottom panel, lanes 4 and
6), Lif1p was no longer targeted to the DNA double-
strand break in the absence of Ku (lane 5). Taken
together, these results reveal that, although Lif1p is
capable of binding linear DNA fragments in vitro, its inter-
action with DNA at the site of a double-strand break
in vivo is dependent on Ku.
In conclusion, the available data suggest that Lif1p func-
tions in multiple ways to potentiate DNA double-strand
break repair by Lig4p. First, Lif1p binds to Lig4p and
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Figure 3
Lif1p stimulates adenylation of and plasmid ligation by Lig4p.
(a) Lig4p adenylation. Increasing amounts (twofold increments) of
purified Lig4p (lanes 1–3), purified Lig4p with a constant excess amount
of recombinant Lif1p (rLif1p; lanes 4–6) or purified Lig4p–Lif1p complex
(lanes 7–9) were incubated with [α-32P]ATP and analysed by SDS–PAGE.
Samples were transferred onto nitrocellulose filters that were then
analysed by western blotting using anti-HA antibody (top panel). The blot
was then stripped of antibody and exposed to autoradiography to detect
radioactively labelled adenylated Lig4p (bottom panel). (b) Plasmid
ligation. No protein or increasing amounts (twofold increments) of purified
Lig4p (lanes 2–4), purified Lig4p with a constant excess amount of rLif1p
(lanes 5–7), rLif1p (lanes 8–10) or the purified Lig4p–Lif1p complex
(lanes 11–13) were incubated with BamHI-linearised pBluescript (which
has a 5′ overhang) and the products were analysed on an agarose gel
stained with ethidium bromide.
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enhances its intracellular stability [5]. Second, Lif1p
stimulates the enzymatic activity of Lig4p, most likely
by stabilising the formation of the activated enzyme-
adenylate complex. Finally, Lif1p has intrinsic DNA-
binding activity and targets Lig4p specifically to sites of
double-strand breaks in a manner that depends on func-
tional Ku. One attractive possibility is that the Ku het-
erodimer directly recruits the Lif1p–Lig4p complex to
sites of DNA damage. Alternatively, or in addition, Ku
might mediate Lif1p recruitment indirectly, through inter-
acting with an intermediary protein or through triggering
alterations in chromatin structure that permit Lif1p access.
At least in vitro, mammalian Ku has previously been shown
to bridge two DNA molecules together [16,17] and this
correlates with its ability to stimulate DNA ligation [18].
The availability of biochemical assays for the various
NHEJ components, and the ability to assess their inter-
actions with the damaged DNA substrate in vivo, should
allow the validity of these and other models to be assessed.
Supplementary material
Supplementary material including yeast strains and methodological
details is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Lif1p binds DNA in vitro and in vivo. (a) Gel retardation assays were
performed using an α32P-labelled 335 bp DNA fragment and increasing
amounts of purified recombinant Lif1p; lanes 1–10 contain 0, 0.5, 1, 2, 4,
6, 8, 10, 16.7 and 20 ng Lif1p, respectively. (b) Chromatin
immunoprecipitations were performed using yeast whole-cell extracts
prepared from strains (see Supplementary material) expressing
(lanes 4–6) or not expressing (lanes 1–3) HO endonuclease, and
antibodies against FLAG-tagged Lif1p (top), HA-tagged Lig4p (middle),
or Lif1p (bottom). PCR reactions were performed on the
immunoprecipitated material and on input genomic DNA using
oligonucleotides that generated a specific 243 bp fragment derived from
a region 400 bp downstream of the HO endonucleolytic site. Control
PCR reactions using the PHO5–1 and PHO5–2 primers
(see Supplementary material) generated a 518 bp fragment at a distant
locus; low levels of this fragment were observed both with or without
induction of the HO endonuclease (data not shown). The resulting PCR
products were analysed on an agarose gel stained with ethidium bromide.
bb10c53.qxd  02/29/2000  04:36  Page 168
